Elizarova Anna, Sokolov Alexey, Kostevich Valeria, Kisseleva Ekaterina, Zelenskiy Evgeny, Zakharova Elena, Panasenko Oleg, Budevich Alexander, Semak Igor, Egorov Vladimir, Pontarollo Giulia, De Filippis Vincenzo, Vasilyev Vadim
Institute of Experimental Medicine, 12 Acad. Pavlov Street, 197376 Saint-Petersburg, Russia.
Chair of Fundamental Problems of Medicine, Saint-Petersburg State University, 7/9 University Embankment, 199034 Saint-Petersburg, Russia.
Materials (Basel). 2021 Mar 25;14(7):1602. doi: 10.3390/ma14071602.
As shown recently, oleic acid (OA) in complex with lactoferrin (LF) causes the death of cancer cells, but no mechanism(s) of that toxicity have been disclosed. In this study, constitutive parameters of the antitumor effect of LF/OA complex were explored. Complex LF/OA was prepared by titrating recombinant human LF with OA. Spectral analysis was used to assess possible structural changes of LF within its complex with OA. Structural features of apo-LF did not change within the complex LF:OA = 1:8, which was toxic for hepatoma 22a cells. Cytotoxicity of the complex LF:OA = 1:8 was tested in cultured hepatoma 22a cells and in fresh erythrocytes. Its anticancer activity was tested in mice carrying hepatoma 22a. In mice injected daily with LF-8OA, the same tumor grew significantly slower. In 20% of animals, the tumors completely resolved. LF alone was less efficient, i.e., the tumor growth index was 0.14 for LF-8OA and 0.63 for LF as compared with 1.0 in the control animals. The results of testing from 48 days after the tumor inoculation showed that the survival rate among LF-8OA-treated animals was 70%, contrary to 0% rate in the control group and among the LF-treated mice. Our data allow us to regard the complex of LF and OA as a promising tool for cancer treatment.
最近的研究表明,油酸(OA)与乳铁蛋白(LF)形成的复合物可导致癌细胞死亡,但该毒性的作用机制尚未明确。在本研究中,我们探索了LF/OA复合物抗肿瘤作用的相关参数。通过用OA滴定重组人LF制备了LF/OA复合物。采用光谱分析评估LF与OA形成复合物后可能发生的结构变化。在LF:OA = 1:8的复合物中,脱铁LF的结构特征未发生改变,该复合物对肝癌22a细胞具有毒性。在培养的肝癌22a细胞和新鲜红细胞中测试了LF:OA = 1:8复合物的细胞毒性。在携带肝癌22a的小鼠中测试了其抗癌活性。在每天注射LF-8OA的小鼠中,相同的肿瘤生长明显减缓。在20%的动物中,肿瘤完全消退。单独使用LF的效果较差,即LF-8OA的肿瘤生长指数为0.14,LF为0.63,而对照组动物的肿瘤生长指数为1.0。肿瘤接种后48天的测试结果表明,LF-8OA治疗组动物的存活率为70%,而对照组和LF治疗组小鼠的存活率为0%。我们的数据使我们有理由将LF和OA的复合物视为一种有前景的癌症治疗工具。